BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9197885)

  • 1. Uterine carcinosarcoma in association with tamoxifen therapy.
    McCluggage WG; McManus DT; Lioe TF; Hill CM
    Br J Obstet Gynaecol; 1997 Jun; 104(6):748-50. PubMed ID: 9197885
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
    Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
    Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
    Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine sarcoma associated with tamoxifen use: case report.
    Martin-Loeches M; Rius J; Orti RM
    Eur J Gynaecol Oncol; 2003; 24(2):202-3. PubMed ID: 12701980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
    Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcoma in association with tamoxifen therapy.
    Oláh KS
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1420. PubMed ID: 9422027
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature.
    Kloos I; Delaloge S; Pautier P; Di Palma M; Goupil A; Duvillard P; Cailleux PE; Lhomme C
    Int J Gynecol Cancer; 2002; 12(5):496-500. PubMed ID: 12366669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian adenosarcoma of the uterus in association with tamoxifen therapy.
    Jessop FA; Roberts PF
    Histopathology; 2000 Jan; 36(1):91-2. PubMed ID: 10681194
    [No Abstract]   [Full Text] [Related]  

  • 10. [The uterine sarcoma, a new risk identified for tamoxifen].
    Baron M; Dessogne P; d'Anjou J
    Presse Med; 2004 Mar; 33(5):321-2. PubMed ID: 15041879
    [No Abstract]   [Full Text] [Related]  

  • 11. HER-2/neu oncogene in uterine carcinosarcoma on tamoxifen therapy.
    Raspollini MR; Mecacci F; Paglierani M; Marchionni M; Taddei GL
    Pathol Res Pract; 2005; 201(2):141-4. PubMed ID: 15901136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus.
    Chourmouzi D; Boulogianni G; Zarampoukas T; Drevelengas A
    AJR Am J Roentgenol; 2003 Dec; 181(6):1673-5. PubMed ID: 14627594
    [No Abstract]   [Full Text] [Related]  

  • 13. Uterine sarcoma after tamoxifen therapy for breast cancer.
    Samuji M; O'Sullivan R; Shireen R
    Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcomas in breast cancer patients treated with tamoxifen.
    Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
    Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine malignant mixed Müllerian tumor after adjuvant tamoxifen treatment for breast cancer.
    Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
    Eur J Gynaecol Oncol; 2013; 34(1):94-8. PubMed ID: 23590011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Incidence of Carcinosarcoma among Patients Previously Treated with Tamoxifen.
    Segev Y; Arnon E; Siegler E; Gemer O; Goldberg Y; Auslender R; Kaldawy A; Lavie O
    Isr Med Assoc J; 2017 Mar; 19(3):164-167. PubMed ID: 28457094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine carcinosarcoma related to tamoxifen.
    McCluggage WG
    Int J Gynecol Cancer; 2003; 13(5):697-8; author reply 697-8. PubMed ID: 14675359
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
    Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
    Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
    Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.